Jack Callicutt
Vermögen: 19 187 $ am 31.05.2026
Vermögen: 19 187 $ am 31.05.2026
Mr. Jack W.
Callicutt, CPA, is a Secretary, Chief Financial & Accounting Officer at Galectin Therapeutics, Inc. Mr. Callicutt was previously employed as a Chief Financial Officer by REACH Health, Inc., a Chief Financial Officer by Vystar Corp., a Chief Financial Officer & Vice President by Tikvah Therapeutics, Inc., a Senior Manager by Deloitte & Touche LLP, a Chief Financial Officer & Secretary by Corautus Genetics, Inc., and a Chief Financial Officer by IVOX, Inc. He received his undergraduate degree from Delta State University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.01.2026 | 7’614 ( 0.01% ) | 19 187 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| GALECTIN THERAPEUTICS INC. | Finanzdirektor/CFO | 01.07.2013 |
| Unternehmen | Position | Ende |
|---|---|---|
REACH Health, Inc.
REACH Health, Inc. Packaged SoftwareTechnology Services Provides telemedicine software solutions for hospitals | Finanzdirektor/CFO | 01.06.2013 |
| VYSTAR CORPORATION | Finanzdirektor/CFO | 01.08.2012 |
Tikvah Therapeutics, Inc.
Tikvah Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutic products | Finanzdirektor/CFO | 01.03.2008 |
Corautus Genetics, Inc.
Corautus Genetics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy pharmaceutical products | Finanzdirektor/CFO | 07.06.2007 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Corporate Officer/Principal | 01.01.2003 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Corautus Genetics, Inc.
Corautus Genetics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy pharmaceutical products | Health Technology |
Galectin Therapeutics, Inc.
Galectin Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs to combat various diseases | Health Technology |
Vystar Corp.
Vystar Corp. Chemicals: SpecialtyProcess Industries Manufactures and distributes natural rubber latex | Process Industries |
Tikvah Therapeutics, Inc.
Tikvah Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutic products | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Delta State University
Delta State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
REACH Health, Inc.
REACH Health, Inc. Packaged SoftwareTechnology Services Provides telemedicine software solutions for hospitals | Technology Services |
IVOX, Inc.
IVOX, Inc. Information Technology ServicesTechnology Services Provides information technology services | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen